Back to School: How biopharma can reboot drug development. Access exclusive analysis here
Coronado began a double-blind, placebo-controlled Phase II trial to evaluate 7,500 Trichuris suis ova given every other
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury